Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
about
Adenosine and hypoxia-inducible factor signaling in intestinal injury and recoveryThe impact of hypoxia on intestinal epithelial cell functions: consequences for invasion by bacterial pathogensOrganoid Models of Human Gastrointestinal Development and DiseaseNeutrophils and inflammatory resolution in the mucosaHypoxia: an alarm signal during intestinal inflammationExposure to concentrated ambient fine particulate matter disrupts vascular endothelial cell barrier function via the IL-6/HIF-1α signaling pathwaySeroreactivity against glycolytic enzymes in inflammatory bowel disease.Contributions of neutrophils to resolution of mucosal inflammation.Boosting the hypoxia-induced adaptive response in inflammatory bowel disease: a novel concept of treatment.Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells.Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancerInduction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory processLayered signaling regulatory networks analysis of gene expression involved in malignant tumorigenesis of non-resolving ulcerative colitis via integration of cross-study microarray profiles.Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis.Hypoxia-inducible factor 1 alpha and vascular endothelial growth factor overexpression in ischemic colitisPathogenesis of Crohn's diseaseThe hypoxia-inflammation link and potential drug targets.Association of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitisImplications of protein post-translational modifications in IBD.Neutrophils and inflammatory metabolism in antimicrobial functions of the mucosa.Ubiquitin protein modification and signal transduction: implications for inflammatory bowel diseases.Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition.Targeting hypoxia in inflammatory bowel diseaseCentral role for endothelial human deneddylase-1/SENP8 in fine-tuning the vascular inflammatory response.Cellular turnover and expression of hypoxic-inducible factor in acute acalculous and calculous cholecystitis.The inflammatory tissue microenvironment in IBD.Genetic deletion of the HIF-1α isoform I.1 in T cells enhances antibacterial immunity and improves survival in a murine peritonitis modelEndothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in miceControl of creatine metabolism by HIF is an endogenous mechanism of barrier regulation in colitis.Hypoxia and Mucosal Inflammation.Hypoxia Positively Regulates the Expression of pH-Sensing G-Protein-Coupled Receptor OGR1 (GPR68)Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory diseaseHypoxia and inflammation.Impeded protein folding and function in active inflammatory bowel disease.Molecular oxygen sensing: implications for visceral surgery.Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis.Hydroxylases as therapeutic targets in inflammatory bowel disease.Persistent organic pollutants meet adipose tissue hypoxia: does cross-talk contribute to inflammation during obesity?The role of hypoxia in inflammatory disease (review)
P2860
Q24620924-25D5C1FC-C788-4E10-B634-E77D1527CF15Q26752794-F5436F75-BD53-4848-971C-B483A8448DC4Q26771646-83091818-2CE3-4674-A532-51C97EC98513Q26827177-708B94BA-A395-450E-ABCC-21D86BC862BCQ27691319-3C530F6B-C299-49A3-940B-AF86E8D7F352Q28383355-C9472D78-9FD3-467C-BF09-DDA903640056Q33632430-50180500-E34B-4C51-8541-78AEAB5D6F00Q33719500-0323F85E-2221-4752-B1AE-605AAB48750DQ33989082-86CF16B2-B302-4640-915F-5CFDA631D97DQ34012826-A70EB6B6-058C-42F2-869B-6E084E4A4C9EQ34039324-5B107CBB-98B2-4495-8D49-DEB07800C831Q34393297-1EB8E27B-2A8A-4A6F-A125-AE734D192E51Q34465254-F3ED45DB-8E1E-4268-B5C1-79C0E3F1D918Q34794766-75C036A0-4A61-41F4-A914-1BC116094E46Q34977591-B35F7B18-DDBB-422C-9BA1-1E875897575BQ35010460-BB396E34-22B2-4BDC-912D-B9BFB9469049Q35659341-61EDB234-56E9-4D03-8894-12F8247A7EC5Q35676172-5303C4EB-8801-43AC-A43A-6C6FED6BE5EAQ35729065-0B652CC9-571C-404B-AD18-D6BFA0C1041BQ36041758-C39862E5-8B10-463B-A40A-E9B9C15C553DQ36057926-24260B7E-FDBF-4E95-8023-2C7C3E4F6482Q36321691-31734FB6-629E-42BA-8785-8E668E861B42Q36372667-7F217234-4921-4FF4-B964-50754F83FA1CQ36386444-55E6A5BE-BA0D-4275-860C-56AD4E3735E1Q36487443-8990DC92-6882-44EC-9352-7A3CC9EEB933Q36916330-12086548-0DAA-4CB3-BFDD-7021F1112EA1Q37110369-D0E06A4F-9927-40E8-9EB6-F2F69FFF6177Q37134080-3428A588-3D75-4779-AFF7-B3B7DC8F0CEEQ37237823-FB082577-ED73-4457-B106-C47DBFDB5396Q37377437-33A1C6BC-5019-419D-905D-C452C8F21838Q37550577-968E1550-FDDF-4557-9EE9-02186A55ACD6Q37594838-50D09603-3E3D-4055-8FAA-84FEAACB5806Q37825687-22000249-B4F2-4EBD-BB4D-4501D9D04624Q37842498-73F12F16-BC71-4F4C-8B9C-C77B735B4C3DQ37905168-A028B548-6AEC-4CD9-B59E-FC0734D31788Q37991141-E32F12D0-C0F4-47E2-9B06-C6E439D11FC3Q37993640-9DDA53F9-5250-488E-86F3-6DAA78B69F9EQ38082620-01C34A7F-76DA-49EC-9C66-09A24DC7F1F5Q38133593-18A10C50-A2B9-4323-9C7F-D860C71B4CF9Q38334119-538F5A4C-3ECB-48FF-AB82-E0BE416C7DE2
P2860
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
@ast
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
@en
type
label
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
@ast
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
@en
prefLabel
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
@ast
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
@en
P2093
P2860
P921
P356
P1476
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease
@en
P2093
A Giatromanolaki
C Simopoulos
D Papazoglou
E Sivridis
K C Gatter
M I Koukourakis
P2860
P304
P356
10.1136/JCP.56.3.209
P407
P577
2003-03-01T00:00:00Z